Effects of a Novel Neurofeedback Protocol on ADHD Subcomponents (NFB@HOME)
Attention Deficit Disorder With Hyperactivity
About this trial
This is an interventional treatment trial for Attention Deficit Disorder With Hyperactivity focused on measuring Electroencephalography, Alpha Rhythm, Attention, Impulsive Behavior, Neurofeedback
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of ADHD
- Currently stabilized (euthymic)
- General good health
- Normal or corrected-to normal visual acuity
Exclusion Criteria:
- Mood Disorders
- PTSD
- Borderline Personality Disorder
- Substance Use Disorder
- Structural Brain Abnormalities
- Cerebrovascular Disease
- Epilepsy
- Stroke
- Head Trauma
- Cardiovascular Disease
- Renal Failure
- Hepatic Dysfunction
- Impaired visual acuity
Sites / Locations
- University Hospitals of GenevaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
NEUROFEEDBACK
CONTROL
Participants undergo individual at home sessions of 45-minute video-replay of popular TV series while recording their 1-channel EEG using a portable system. Self-regulation of alpha rhythm is reflected in the dynamically varying opacity of the video replay window, i.e. the window would turn lighter/darker and reveal/obscure video content during episodes of low/high alpha amplitude, respectively.
Participants undergo individual at home sessions of 45-minute video-replay of popular TV series while recording their 1-channel EEG using a portable system. The recording is passive without real-time EEG neurofeedback (i.e. constant brightness and volume).